Growing community of inventors

Paris, France

Jean-Paul Pierre Potier

Average Co-Inventor Count = 6.86

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Jean-Paul Pierre PotierJoanna Bakala (1 patent)Jean-Paul Pierre PotierRobert H Dodd (1 patent)Jean-Paul Pierre PotierJérôme Bignon (1 patent)Jean-Paul Pierre PotierUrs Thomet (1 patent)Jean-Paul Pierre PotierRoman Furtmuller (1 patent)Jean-Paul Pierre PotierErwin Sigel (1 patent)Jean-Paul Pierre PotierWerner Sieghart (1 patent)Jean-Paul Pierre PotierFrantisek Jursky (1 patent)Jean-Paul Pierre PotierNathalie Cheviron (1 patent)Jean-Paul Pierre PotierAhmed El Hadri (1 patent)Jean-Paul Pierre PotierYves Fromes (1 patent)Jean-Paul Pierre PotierFrançoise Lawrence (1 patent)Jean-Paul Pierre PotierJean-Paul Pierre Potier (2 patents)Joanna BakalaJoanna Bakala (10 patents)Robert H DoddRobert H Dodd (9 patents)Jérôme BignonJérôme Bignon (7 patents)Urs ThometUrs Thomet (2 patents)Roman FurtmullerRoman Furtmuller (2 patents)Erwin SigelErwin Sigel (2 patents)Werner SieghartWerner Sieghart (2 patents)Frantisek JurskyFrantisek Jursky (2 patents)Nathalie ChevironNathalie Cheviron (1 patent)Ahmed El HadriAhmed El Hadri (1 patent)Yves FromesYves Fromes (1 patent)Françoise LawrenceFrançoise Lawrence (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,680 patents)

2. Centre National De La Recherche Scientifique (1 from 5,069 patents)


2 patents:

1. 7235532 - Angiogenic agents and their uses

2. 6660769 - N substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones for use as promoter of &ggr;-aminobutyric acid activity and for treating nervous disorders and preparation method

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…